Effect of Long-Term Use of Tenofovir (TDF) on Bone Density in Patients With Chronic Hepatitis B

Not yet recruitingOBSERVATIONAL

Enrollment

172

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

June 1, 2026

Conditions

Tenofovir Disoproxil FumarateBone DensityChronic HBV Infection

Interventions

DRUG

TDF (Tenofovir)

ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION

Trial Locations (1)

Faculty of Medicine, Assuit, Asyut

All Listed Sponsors

lead

Assiut University

OTHER

NCT06990438 - Effect of Long-Term Use of Tenofovir (TDF) on Bone Density in Patients With Chronic Hepatitis B | Biotech Hunter | Biotech Hunter